195 Biomarkers for response to lenalidomide (LEN) treatment in patients with myelodysplastic syndromes (MDS) - Burbury, K.; Gambell, P.; Neeson, P.; Chen, K.; Kenealy, M.; Seymour, J.F.; Prince, H.M.; Westerman, D.; Ritchie, D. (Leukemia Research, 2011)